Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robert Nelsen currently holds 90,000 shares of Juno Therapeutics, Inc. (JUNO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Nelsen has been a net buyer of JUNO stock. They have purchased $127.6M and sold $20.7M worth of shares.
Robert Nelsen's most recent insider trade was on Jun 4, 2026, when they sold 90,000 shares at $0.00 per share.
Robert Nelsen serves as Executive at Juno Therapeutics, Inc. (JUNO). They have executed 276 insider transactions totaling $148.4M over their tenure at the company.
Robert Nelsen holds the position of Executive at Juno Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Robert Nelsen has shown a buying trading pattern, with $127.6M in total purchases and $20.7M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Robert Nelsen was on Sep 19, 2023, when they purchased $25.5M worth of NMRA shares. This transaction involved 1,500,000 shares at $17.00 per share.
Robert Nelsen currently owns 90,000 shares of Juno Therapeutics, Inc. (JUNO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robert Nelsen's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robert Nelsen has 276 Form 4 filings on record as an insider at Juno Therapeutics, Inc..
Set alerts for Robert Nelsen and 40,000+ other insiders.